Coronavirus Update: COVID subvariant dominant in northeastern U.S. has a growth advantage and may have greater ability to evade immunity than earlier strains, WHO says

XBB.1.5 has a growth advantage over other omicron subvariants, and early data suggest it has a greater ability to evade immunity, as well.

Posted

January 12, 2023